Vuong Trieu - 26 Sep 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 26 Sep 2022
Net transactions value: +$1,360
Form type: 4
Filing time: 28 Sep 2022, 09:15:09 UTC
Previous filing: 29 Aug 2022
Next filing: 25 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$1,360	+20,000	+0.02%	$0.0680	90,368,021	26 Sep 2022	Direct
holding	OTLC	Common Stock						16,780,384	26 Sep 2022	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	26 Sep 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 20,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on September 26, 2022 from the open market at a price of $0.068.